EcoDrugPlus

Amine Oxidase Copper Containing 1

Ensembl ID : ENSOJAG00000022784
Gene Symbol: AOC1
1 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSOJAG00000000461
Gene Symbol: AOC2
1 Cross references
403 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSOJAG00000013473
Gene Symbol: APPB
1 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSOJAG00000002973
Gene Symbol: APP
1 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSOJAG00000015864
Gene Symbol: AR
1 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSOJAG00000014588
Gene Symbol: AGTR2
1 Cross references
185 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSOJAG00000010387
Gene Symbol: APLNR2
1 Cross references
171 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSOJAG00000005573
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSOJAG00000012713
Gene Symbol: ALOX5A
1 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSOJAG00000021084
Gene Symbol: ALOX5AP
1 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOJAG00000014929
Gene Symbol: AVPR1A
1 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSOJAG00000004756
Gene Symbol: AVPR1AB
1 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).